IMPACT BIOMEDICAL INC.
For the period ended Jun 30, 2026. Filed Aug 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 7, 2026
IBO$4.10-6.8%Stored close · as of Nov 6, 2026
Contents
Item 1. Condensed Consolidated Balance Sheets as of June 30, 2026 (Unaudited) and December 31, 2025
Condensed Consolidated Balance Sheets
| June 30, 2026 (unaudited) | December 31, 2025 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash | $10,000 | $3,000 |
| Accounts receivable | - | 5,000 |
| Inventory | 62,000 | 63,000 |
| Current portion of notes receivable | 197,000 | 198,000 |
| Prepaid expenses and other current assets | 51,000 | 142,000 |
| Total current assets | 320,000 | 411,000 |
| Other intangible assets, net | 16,425,000 | 16,994,000 |
| Total assets | $16,745,000 | $17,405,000 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $467,000 | $347,000 |
| Accrued expenses | 248,000 | 194,000 |
| Due to related party | 1,330,000 | 621,000 |
| Total current liabilities | 2,045,000 | 1,162,000 |
| Deferred tax liability, net | 688,000 | 688,000 |
| Total liabilities | 2,733,000 | 1,850,000 |
| Commitments and contingencies (Note 9) | - | - |
| Stockholders’ equity | ||
| Preferred stock, $0.001 par value; 100,000,000 shares authorized, zero shares issued and outstanding (zero on December 31, 2025) | - | - |
| Common stock, $0.001 par value; 4,000,000,000 shares authorized, 107,821,231 shares issued and outstanding (104,621,231 on December 31, 2025) | 108,000 | 105,000 |
| Additional paid-in capital | 63,150,000 | 61,713,000 |
| Accumulated deficit | (52,492,000) | (49,507,000) |
| Total stockholders’ equity of the Company | 10,766,000 | 12,311,000 |
| Non-controlling interest in subsidiaries | 3,246,000 | 3,244,000 |
| Total stockholders’ equity | 14,012,000 | 15,555,000 |
| Total liabilities and stockholders’ equity | $16,745,000 | $17,405,000 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.